ProQR Announces R&D Day and Provides Update on Innovation Portfolio Press release First Investor R&D Day on March 14, 2016 in New York, NY November 30, 2015
ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials Press release LEIDEN, The Netherlands, Nov. 23, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 23, 2015
ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences Press release LEIDEN, Netherlands, Oct. 1, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 01, 2015
ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable Press release LEIDEN, the Netherlands, Sept. 23, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 23, 2015
ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment Press release LEIDEN, the Netherlands, Sept. 14, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that PQ-010-002 is open for enrollment. September 14, 2015
ProQR Announces Results for the Second Quarter of 2015 Press release LEIDEN, the Netherlands, Aug. 19, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. August 19, 2015
ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients Press release LEIDEN, the Netherlands, June 26, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. June 26, 2015
ProQR to Present at the JMP Securities Life Science Conference Press release LEIDEN, the Netherlands, June 16, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. June 16, 2015
ProQR Therapeutics Announces Results for the First Quarter of 2015 Press release LEIDEN, the Netherlands, May 21, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. May 21, 2015
ProQR Therapeutics Announces Annual Shareholder Meeting Press release LEIDEN, the Netherlands, April 29, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 29, 2015